Lm. Epstein et al., Initial experience with larger laser sheaths for the removal of transvenous pacemaker and implantable defibrillator leads, CIRCULATION, 100(5), 1999, pp. 516-525
Citations number
8
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background-In a previous randomized trial, the 12F laser sheath removed pac
ing leads via the implant vein more successfully than traditional mechanica
l tools alone. Two larger sizes of laser sheath, the 14F and 16F models, we
re developed to extract defibrillator leads and large-diameter pacing leads
implanted For the chronic. These devices use pulsed ultraviolet laser ligh
t to core though fibrotic tissue grown over the lead body to free the lead
from the vasculature, A mandatory prospective registry studied the safety a
nd effectiveness profiles of the larger laser sheaths vis-a-vis the 12F las
er sheath.
Methods and Results-In this study, 863 patients underwent extraction of 128
5 leads at 52 sites. Patients treated with the 14F device tended to have ol
der leads than the 12F population; the 16F population, which comprised most
ly defibrillator patients, were younger, had younger leads, and were more o
ften male than the 12F population. Clinical success (extracting the entire
lead or the lead body minus the distal electrode) was observed in 91% to 92
% of cases fur all device sizes. The overall complication rate was 3.6%, wi
th 0.8% perioperative mortality. Incidence of complications was independent
of laser sheath size.
Conclusions-The 14F and 16F laser sheaths offer an extraction option for la
rger long-term transvenous pacemaker and defibrillator leads that is as saf
e and effective as the 12F laser sheath.